Evotec SE (EVOTF) Cash from Financing Activities (2021 - 2026)

Evotec SE's (EVOTF) quarterly Cash from Financing Activities came in at -$22349.5 in Q1 2026, down 159.97% year-on-year from $37267.2 in Q1 2025, and up 99.95% quarter-over-quarter from -$43.8 million in Q4 2025.

Evotec SE (EVOTF) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Evotec SE has disclosed Cash from Financing Activities across 6 years of filings, most recently posting -$22349.5 for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$22349.5, down 159.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$43.9 million (up 74.56% YoY), and the FY2025 annual result was -$43.8 million, up 74.61% from the prior year.
  • Cash from Financing Activities came in at -$22349.5 for Q1 2026 at Evotec SE, up from -$43.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $77.4 million in Q4 2023 to a low of -$172.4 million in Q4 2024.
  • The 5-year median for Cash from Financing Activities is -$7889.6 (2024), against an average of -$11.7 million.
  • Across the five-year window, Cash from Financing Activities surged 991.27% in 2023 and plunged 1780.81% in 2024, its largest moves.
  • Evotec SE's Cash from Financing Activities stood at -$59.3 million in 2022, then jumped by 230.55% to $77.4 million in 2023, then plunged by 322.75% to -$172.4 million in 2024, then surged by 74.58% to -$43.8 million in 2025, then soared by 99.95% to -$22349.5 in 2026.
  • The last three Cash from Financing Activities figures came in at -$22349.5 (Q1 2026), -$43.8 million (Q4 2025), and -$14185.3 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Evotec SE - - - -22,349.53

Historic Data

Download Data
DateValue
Mar 31, 2026 -22,349.53
Mar 31, 2026 -22,349.53
Dec 31, 2025 -43.81 Mn
Dec 31, 2025 -43.81 Mn
Sep 30, 2025 -14,185.31
Sep 30, 2025 -14,185.31
Jun 30, 2025 -16,635.28
Jun 30, 2025 -16,635.28
Mar 31, 2025 37,267.21
Mar 31, 2025 37,267.21
Dec 31, 2024 -172.35 Mn
Dec 31, 2024 -172.35 Mn
Sep 30, 2024 -7,889.61
Sep 30, 2024 -7,889.61
Jun 30, 2024 -128,192.70
Jun 30, 2024 -128,192.70
Mar 31, 2024 -6,378.03
Mar 31, 2024 -6,378.03
Dec 31, 2023 77.38 Mn
Dec 31, 2023 77.38 Mn